Citations (20)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Yao-Dung Hsieh, Chao-Chuan Chi, Chiang-Ting Chou, Jin-Shiung Cheng, Chun-Chi Kuo, Wei-Zhe Liang, Ko-Long Lin, Li-Ling Tseng & Chung-Ren Jan. (2011) Investigation of carvedilol-evoked Ca2+ movement and death in human oral cancer cells. Journal of Receptors and Signal Transduction 31:3, pages 220-228.
Read now
Read now
Articles from other publishers (19)
Rasha M. S. M. Mohamed, Shimaa M. Elshazly, Ola E. Nafea & Dalia M. Abd El Motteleb. (2021) Comparative cardioprotective effects of carvedilol versus atenolol in a rat model of cardiorenal syndrome type 4. Naunyn-Schmiedeberg's Archives of Pharmacology 394:10, pages 2117-2128.
Crossref
Crossref
Alexander Kalinkovich & Gregory Livshits. (2021) Biased and allosteric modulation of bone cell-expressing G protein-coupled receptors as a novel approach to osteoporosis therapy. Pharmacological Research 171, pages 105794.
Crossref
Crossref
Daniele Masarone, Maria Luigia Martucci, Vittoria Errigo & Giuseppe Pacileo. (2021) The Use of β-Blockers in Heart Failure with Reduced Ejection Fraction. Journal of Cardiovascular Development and Disease 8:9, pages 101.
Crossref
Crossref
Moran S. Saghiv & Michael S. SagivMoran S. Saghiv & Michael S. Sagiv. 2020. Basic Exercise Physiology. Basic Exercise Physiology
285
369
.
ScheylaDaniela Siqueira Jørgensen, Thomas Rades, Huiling Mu, Kirsten Graeser & Anette Müllertz. (2019) Exploring the utility of the Chasing Principle: influence of drug-free SNEDDS composition on solubilization of carvedilol, cinnarizine and R3040 in aqueous suspension. Acta Pharmaceutica Sinica B 9:1, pages 194-201.
Crossref
Crossref
Zubi Sadiq, Erum Akbar Hussain, Narjis Naz, Ambreen Ghani, Kausar Yasmeen & Fizzah Iqbal. (2017) Microwave-Assisted Synthesis of Tetrahydrocarbazole Linked 1,2-Diazoles in Aqueous-Brønsted Acid Catalytic System. Journal of Chemistry 2017, pages 1-17.
Crossref
Crossref
Carlos A. Rezende, Rosane A.S. San Gil, Leandro B. Borré, José Ricardo Pires, Viviane S. Vaiss, Jackson A.L.C. Resende, Alexandre A. Leitão, Ricardo B. De Alencastro & Katia Z. Leal. (2016) Combining Nuclear Magnetic Resonance Spectroscopy and Density Functional Theory Calculations to Characterize Carvedilol Polymorphs. Journal of Pharmaceutical Sciences 105:9, pages 2648-2655.
Crossref
Crossref
Ruben Vardanyan & Victor Hruby. 2016. Synthesis of Best-Seller Drugs. Synthesis of Best-Seller Drugs
201
214
.
Dmitry A. Chistiakov, Kenneth W. Ashwell, Alexander N. Orekhov & Yuri V. Bobryshev. (2015) Innervation of the arterial wall and its modification in atherosclerosis. Autonomic Neuroscience 193, pages 7-11.
Crossref
Crossref
Mustafa Karabacak, Abdullah Dogan, Fatih Aksoy, Mehmet Ozaydin, Dogan Erdogan & Pinar Karabacak. (2013) Both Carvedilol and Nebivolol May Improve Platelet Function and Prothrombotic State in Patients With Nonischemic Heart Failure. Angiology 65:6, pages 533-537.
Crossref
Crossref
Valentina N. Nikolic, Slobodan M. Jankovic, Radmila Velickovic-Radovanovlć, Svetlana Apostolovlć, Dragana Stanojevic, Slavoljub Zivanovic, Nikola Stefanovic, Srdjan Pesic, Tatjana Jevtovic-Stoimenov, Janko Djuric, Veroljub Markovic & Jasmina R. Milovanovic. (2013) Population Pharmacokinetics of Carvedilol in Patients with Congestive Heart Failure. Journal of Pharmaceutical Sciences 102:8, pages 2851-2858.
Crossref
Crossref
Tania Ferrer, Daniela Ponce-Balbuena, Angélica López-Izquierdo, Ivan A. Aréchiga-Figueroa, Teun P. de Boer, Marcel A.G. van der Heyden & José A. Sánchez-Chapula. (2011) Carvedilol inhibits Kir2.3 channels by interference with PIP2-channel interaction. European Journal of Pharmacology 668:1-2, pages 72-77.
Crossref
Crossref
Ravinder K. WaliMalini IyengarGerald J. BeckDavid M. ChartyanMichel ChoncholMary Ann LukasChristopher CooperJonathan HimmelfarbMatthew R. WeirTomas BerlWilliam L. HenrichAlfred K. Cheung. (2011) Efficacy and Safety of Carvedilol in Treatment of Heart Failure with Chronic Kidney Disease. Circulation: Heart Failure 4:1, pages 18-26.
Crossref
Crossref
Pochuen Shieh, Chih-Hung Lee, Ng Ling Yi & Chung-Ren Jan. (2009) Carvedilol-induced elevation in cytosolic free Ca2+ level and apoptosis in SIRC corneal epithelial cells. Human & Experimental Toxicology 29:6, pages 477-487.
Crossref
Crossref
José Marín-GarcíaJosé Marín-García. 2010. Heart Failure. Heart Failure
213
231
.
Priscila Abreu Sperandio, Audrey Borghi-Silva, Adriano Barroco, Luiz Eduardo NeryDirceu R. Almeida & J. Alberto Neder. (2009) Microvascular oxygen delivery-to-utilization mismatch at the onset of heavy-intensity exercise in optimally treated patients with CHF. American Journal of Physiology-Heart and Circulatory Physiology 297:5, pages H1720-H1728.
Crossref
Crossref
Milica Bajcetic, Aleksandra Nikolic Kokic, Milan Djukic, Jovan Kosutic, Jadranka Mitrovic, Dejan Mijalkovic, Ida Jovanovic, Slavko Simeunovic, Mihajlo B. Spasic & Ranka Samardzic. (2008) Effects of Carvedilol on Left Ventricular Function and Oxidative Stress in Infants and Children with Idiopathic Dilated Cardiomyopathy: A 12-Month, Two-Center, Open-Label Study. Clinical Therapeutics 30:4, pages 702-714.
Crossref
Crossref
Jin-Shiung Cheng, Chorng-Chih Huang, Chiang-Ting Chou & Chung-Ren Jan. (2007) Mechanisms of carvedilol-induced [Ca2+]i rises and death in human hepatoma cells. Naunyn-Schmiedeberg's Archives of Pharmacology 376:3, pages 185-194.
Crossref
Crossref
Brent A. French & Christopher M. Kramer. (2007) Mechanisms of postinfarct left ventricular remodeling. Drug Discovery Today: Disease Mechanisms 4:3, pages 185-196.
Crossref
Crossref